Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
4,404,649
-
Total 13F shares
-
1,834,344
-
Share change
-
+1,834,011
-
Total reported value
-
$20,519,000
-
Price per share
-
$11.18
-
Number of holders
-
19
-
Value change
-
+$20,515,991
-
Number of buys
-
18
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q2 2021
As of 30 Jun 2021,
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,834,344 shares.
The largest 10 holders included
FMR LLC, Rock Springs Capital Management LP, Foresite Capital Management IV, LLC, FIL Ltd, NEA Management Company, LLC, Monashee Investment Management LLC, Maven Securities LTD, Ikarian Capital, LLC, VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.